2000
DOI: 10.1053/ajkd.2000.19085
|View full text |Cite
|
Sign up to set email alerts
|

A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
13
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 30 publications
4
13
0
Order By: Relevance
“…Our finding of a positive correlation between the concentrations of serum folate and plasma cysteine in healthy subjects is in agreement with the observation made in patients on kidney dialysis [16]. However, one study reported a negative relationship between the concentrations of serum folate and plasma cysteine, whereas no relationship was observed in two other studies [17,18].…”
Section: Discussionsupporting
confidence: 92%
“…Our finding of a positive correlation between the concentrations of serum folate and plasma cysteine in healthy subjects is in agreement with the observation made in patients on kidney dialysis [16]. However, one study reported a negative relationship between the concentrations of serum folate and plasma cysteine, whereas no relationship was observed in two other studies [17,18].…”
Section: Discussionsupporting
confidence: 92%
“…Fundamental design differences in CREED, such as exclusion of those with preexisting cardiovascular disease or on folic acid supplementation, make direct comparisons difficult. The lack of association between C677T genotype of MTHFR and outcomes is consistent with findings of a meta-analysis (21) and a study in Japanese hemodialysis patients (27).…”
Section: Discussionsupporting
confidence: 89%
“…Similar results were obtained in studies of Asians reported by Sun et al [26] and Mtiraoui et al [27]. In studies of Japanese hemodialysis patients, Kimura et al [22] investigated the association between MTHFR C677T and hyperhomocysteinemia, and Morimoto et al [11] investigated MTHFR C677T, hyperhomocysteinemia, and risk of cardiovascular disease, but they did not investigate whether the polymorphism is a risk factor for nephropathy. However, they investigated the genotype frequency of MTHFR C677T in hemodialysis patients, and the frequency of the TT genotype was similar to those reported by Sun et al [26] and Mtiraoui et al [27].…”
Section: Discussionsupporting
confidence: 68%
“…The frequencies of CC, CT, and TT genotypes of MTHFR C677T were 29.5, 43.6, and 26.9 %, respectively, and the frequency of TT genotype was significantly higher than the frequency of that in Japanese hemodialysis patients as reported by Morimoto et al (13.7 %) [11] and Kimura et al (17.4 %) [22] and healthy Japanese (about 15 %) [23,24]. Many studies reported that MTHFR C677T polymorphism is a risk factor for nephropathy, and a significantly high frequency of the TT genotype in nephropathy patients was also detected in a meta-analysis conducted by Yang et al [25].…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation